Novo Nordisk A/S (NYSE:NVO) is one of the top NYSE stocks with the highest upside potential. On August 5, UBS downgraded Novo ...

COMPANY ANNOUNCEMENT No. 230/2025 Tvis, 6 August 2025 TCM Group A/S revise full year guidance for 2025 As the closing of the ...

Orion Oyj Series A posted the largest decline among large stocks during the session, declining 7.8%, followed by Embla Medical hf. shares, which declined 7.7%. Shares of Orion Oyj Series B declined ...

The drugmaker released its second-quarter earnings report early Wednesday as it vowed to cut costs amid intensifying ...

Maziar Mike Doustdar, who was named as Novo Nordisk’s new CEO last week, spoke on a second quarter earnings call of ...

Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish ...

MFPEN, Nicklas Skovgaard, and STEL are the finalists for the 2025 Wessel & Vett Fashion Prize. The winner receives 67,000 ...

Novo Nordisk reported 18% sales growth in the first half of 2025, despite a profit warning that triggered a record share drop ...

The dollar was flat. There has been a "small softening" in risk sentiment, NAB's Tapas Strickland said, citing softness in the ISM services report released overnight and Trump's plan to roll out ...

Amidst challenging market environment DSV’s Q2 performance was bolstered by early gains from its acquisition of Schenker.

Two brooches from Denmark are unique examples of Viking Age goldwork that includes Christian and Norse designs.